Answer
Fluvastatin competitively inhibits HMG-CoA reductase, mainly in the liver, reducing cholesterol synthesis and stimulating LDL receptor production, which increases LDL particle uptake and lowers plasma cholesterol.
Sources for this answer
- Fluvastatin 20 mg CapsulesSandoz Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 9Document updated
Sources checked